Overview

Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
Study to look at safety and effectiveness of different doses of tadalafil on prostate related genital/urinary tract problems.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
ICOS Corporation
Treatments:
Tadalafil